About us

E25Bio revolves around an idea that technology that saves lives is in fact simple.
Our goal is to predict outbreaks around the world and help control them using unique and affordable testing solutions.

We've managed to develop an investigational SARS and SARS-CoV-2 rapid tests in 3 weeks

2020

jan

30

SARS-CoV-2 is a PHEIC

2020

feb

06

E25Bio high-throughput screen of existing mAbs

2020

feb

26

E25Bio develops SARS-CoV-2 rapid test

2020

mar

20

E25Bio partners with top academic Boston hospitals for scaled evaluation and production

After FDA EUA

Future
launch of rapid tests

After FDA EUA

Future
launch of rapid tests

Meet the team

Of scientists who invented and are developing an inexpensive yet accurate means of testing for COVID-19 and the people making it happen

Prashant Chouta

CEO


Irene Bosch, PhD

Co-founder & CTO


Bobby Brooke Herrera, PhD

Co-founder & CSO


Lee Gehrke, PhD

Co-founder/Scientific Advisory Board


Nol Salcedo, MSc

Scientist


Adam Gomez, MSc

Scientist


Carlos-Henri Ferré, MA

Director of Operations and Communications


Nik Lal

Design Engineer


Our investors

 

Without them, E25Bio wouldn’t be what it is today. So, the least we can do is to mention them.